Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain

Conditions

• Pain
• Nausea
• Vomiting

Interventions

• DRUG: CL-108 (hydrodocone 7.5 mg, acetaminophen 325 mg, promethazine 12.5 mg)
• DRUG: Placebo

Sponsor

Charleston Laboratories, Inc